The case for dual Renin-Angiotensin system inhibition.
Hirsch
Sheldon
S
D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006801:Humans; D011379:Prognosis; D011507:Proteinuria / Q000175:diagnosis / Q000188:drug therapy; D044139:Receptor, Angiotensin, Type 2 / Q000008:administration & dosage; D051437:Renal Insufficiency / Q000175:diagnosis / Q000188:drug therapy*; D012084:Renin-Angiotensin System / Q000187:drug effects*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D044139:Receptor, Angiotensin, Type 2